Latest Insider Transactions at Solid Biosciences Inc. (SLDB)
This section provides a real-time view of insider transactions for Solid Biosciences Inc. (SLDB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Solid Biosciences Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Solid Biosciences Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 21
2024
|
Gabriel Brooks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,923
-21.03%
|
$17,538
$6.5 P/Share
|
|
Oct 18
2024
|
Gabriel Brooks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,750
+41.22%
|
-
|
|
Oct 03
2024
|
Ian F Smith |
BUY
Exercise of conversion of derivative security
|
Direct |
3,255
+2.88%
|
-
|
|
Jul 03
2024
|
Ian F Smith |
BUY
Exercise of conversion of derivative security
|
Direct |
3,255
+2.97%
|
-
|
|
Jun 07
2024
|
Clare Kahn |
BUY
Open market or private purchase
|
Direct |
1,100
+50.0%
|
$7,700
$7.67 P/Share
|
|
May 02
2024
|
Ilan Ganot |
SELL
Open market or private sale
|
Indirect |
462
-4.63%
|
$4,620
$10.33 P/Share
|
|
May 02
2024
|
Ilan Ganot |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,553
+13.48%
|
-
|
|
Apr 03
2024
|
Ian F Smith |
BUY
Exercise of conversion of derivative security
|
Direct |
3,256
+3.06%
|
-
|
|
Jan 29
2024
|
Ilan Ganot |
SELL
Open market or private sale
|
Indirect |
139
-1.62%
|
$973
$7.99 P/Share
|
|
Jan 27
2024
|
Ilan Ganot |
BUY
Exercise of conversion of derivative security
|
Direct |
3,883
+3.93%
|
-
|
|
Jan 27
2024
|
Ilan Ganot |
BUY
Exercise of conversion of derivative security
|
Indirect |
388
+4.34%
|
-
|
|
Jan 11
2024
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
3,410,713
+33.29%
|
$17,053,565
$5.53 P/Share
|
|
Jan 11
2024
|
Bain Capital Life Sciences Investors, LLC |
BUY
Grant, award, or other acquisition
|
Indirect |
904,160
+18.31%
|
$4,520,800
$5.53 P/Share
|
|
Jan 11
2024
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
904,160
+17.74%
|
$4,520,800
$5.53 P/Share
|
|
Jan 11
2024
|
Adam Koppel |
BUY
Grant, award, or other acquisition
|
Indirect |
904,160
+18.31%
|
$4,520,800
$5.53 P/Share
|
|
Jan 09
2024
|
Kevin Tan CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
3,935
-29.71%
|
$31,480
$8.2 P/Share
|
|
Jan 09
2024
|
Kevin Tan CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+45.93%
|
-
|
|
Jan 03
2024
|
Ilan Ganot |
SELL
Open market or private sale
|
Indirect |
1,142
-12.27%
|
$5,710
$5.3 P/Share
|
|
Jan 03
2024
|
Ilan Ganot |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,993
+24.33%
|
-
|
|
Jan 03
2024
|
Ian F Smith |
BUY
Exercise of conversion of derivative security
|
Direct |
15,570
+13.48%
|
-
|
|
Dec 04
2023
|
Alexander Cumbo President and CEO |
SELL
Open market or private sale
|
Direct |
11,757
-40.27%
|
$23,514
$2.77 P/Share
|
|
Dec 04
2023
|
Jennifer Marlowe CSO |
SELL
Open market or private sale
|
Direct |
4,890
-41.13%
|
$9,780
$2.77 P/Share
|
|
Dec 04
2023
|
Jessie Hanrahan Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
4,879
-41.13%
|
$9,758
$2.78 P/Share
|
|
Dec 04
2023
|
Paul Herzich Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,968
-41.01%
|
$5,936
$2.77 P/Share
|
|
Dec 04
2023
|
David T Howton Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,367
-41.12%
|
$10,734
$2.78 P/Share
|
|
Dec 02
2023
|
Alexander Cumbo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,612
+49.49%
|
-
|
|
Dec 02
2023
|
Jennifer Marlowe CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,888
+50.0%
|
-
|
|
Dec 02
2023
|
Jessie Hanrahan Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,862
+50.0%
|
-
|
|
Dec 02
2023
|
Paul Herzich Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,238
+50.0%
|
-
|
|
Dec 02
2023
|
David T Howton Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,051
+50.0%
|
-
|
|
Dec 02
2023
|
Ilan Ganot |
BUY
Exercise of conversion of derivative security
|
Direct |
1,583
+1.71%
|
-
|
|
Oct 03
2023
|
Ian F Smith |
BUY
Exercise of conversion of derivative security
|
Direct |
15,569
+15.58%
|
-
|
|
Sep 02
2023
|
Ilan Ganot |
BUY
Exercise of conversion of derivative security
|
Direct |
1,583
+1.74%
|
-
|
|
Jul 03
2023
|
Ian F Smith |
BUY
Exercise of conversion of derivative security
|
Direct |
15,570
+18.45%
|
-
|
|
Jun 02
2023
|
Ilan Ganot |
BUY
Exercise of conversion of derivative security
|
Direct |
1,583
+1.77%
|
-
|
|
May 02
2023
|
Ilan Ganot |
SELL
Open market or private sale
|
Indirect |
487
-10.5%
|
$1,948
$4.85 P/Share
|
|
May 02
2023
|
Ilan Ganot |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,553
+25.08%
|
-
|
|
Apr 03
2023
|
Ian F Smith |
BUY
Exercise of conversion of derivative security
|
Direct |
15,569
+22.63%
|
-
|
|
Mar 02
2023
|
Ilan Ganot |
BUY
Exercise of conversion of derivative security
|
Direct |
1,584
+1.8%
|
-
|
|
Jan 27
2023
|
Ilan Ganot |
SELL
Open market or private sale
|
Direct |
1,382
-1.61%
|
$9,674
$7.49 P/Share
|
|
Jan 27
2023
|
Ilan Ganot |
BUY
Exercise of conversion of derivative security
|
Direct |
3,883
+4.32%
|
-
|
|
Jan 27
2023
|
Ilan Ganot |
SELL
Open market or private sale
|
Indirect |
141
-9.28%
|
$987
$7.49 P/Share
|
|
Jan 27
2023
|
Ilan Ganot |
BUY
Exercise of conversion of derivative security
|
Indirect |
388
+20.35%
|
-
|
|
Jan 27
2023
|
Carl Ashley Morris Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
441
-2.18%
|
$3,087
$7.49 P/Share
|
|
Jan 27
2023
|
Carl Ashley Morris Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,233
+5.75%
|
-
|
|
Jan 03
2023
|
Ian F Smith |
BUY
Exercise of conversion of derivative security
|
Direct |
1,620
+4.12%
|
-
|
|
Dec 02
2022
|
Perceptive Advisors LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,601,763
+33.69%
|
$18,212,341
$7.05 P/Share
|
|
Dec 02
2022
|
Ian F Smith |
BUY
Grant, award, or other acquisition
|
Direct |
13,172
+3.56%
|
-
|
|
Dec 02
2022
|
Alexander Cumbo President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
584
+50.0%
|
-
|
|
Dec 02
2022
|
Ra Capital Management, L.P. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,573,193
+33.46%
|
$18,012,351
$7.05 P/Share
|